Trial intelligence / Profile preview

Palliative treatment of ulcerated cutaneous metastases: electrochemotherapy vs radiotherapy

2009-011455-51Phase 2Terminated

Sponsor
Department of Oncology, Herlev University Hospital
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of bleomycin in cutaneous metastases and Non-hematologic malignancy (2 arms), sponsored by Department of Oncology, Herlev University Hospital. Primary endpoint: Response rate. Started Apr 2009; status: terminated.

02

Drugs

bleomycin
03

Conditions

cutaneous metastasesNon-hematologic malignancy

Beyond the preview

Go deeper on 2009-011455-51.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011455-51.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call